Use of a dietary supplement, PectaSol (modified citrus pectin) has shown continued benefit among men with prostate cancer, according to results from 18 months of follow-up.
“This study confirmed results seen in two previous, smaller studies,” Dr. Daniel Keizman, the principal investigator of the multicenter phase 2b clinical trial being conducted in Israel, said in a press release. “The interim results of the 18 months long-term follow up, are demonstrating the potential of this specific modified citrus pectin) to benefit prostate cancer patients with biochemical relapse for long periods of time.”